Literature DB >> 17090203

Hamartomatous polyps of the colon: ganglioneuromatous, stromal, and lipomatous.

Owen T M Chan1, Parviz Haghighi.   

Abstract

Intestinal ganglioneuromas comprise benign, hamartomatous polyps characterized by an overgrowth of nerve ganglion cells, nerve fibers, and supporting cells in the gastrointestinal tract. This polyposis has been divided into 3 subgroups, each with a different degree of ganglioneuroma formation: polypoid ganglioneuroma, ganglioneuromatous polyposis, and diffuse ganglioneuromatosis. The ganglioneuromatous polyposis subgroup is not known to coexist with systemic disorders that often have an associated intestinal polyposis, such as multiple endocrine neoplasia type IIb, neurofibromatosis type I, and Cowden syndrome. We report a case of ganglioneuromatous polyposis plus cutaneous lipomatosis in a 41-year-old man with no established systemic disease. However, he possessed unique anatomic findings in addition to his ganglioneuromatosis, suggesting that the ganglioneuromatosis-lipomatosis in our patient may represent an unrecognized syndrome. This case report and brief review of the literature provide an overview of intestinal ganglioneuromatosis in relation to the hereditary polyposis syndromes and describe the individual ganglioneuromatosis subgroups.

Entities:  

Mesh:

Year:  2006        PMID: 17090203     DOI: 10.5858/2006-130-1561-HPOTCG

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  22 in total

1.  Chronic Constipation Caused by Neurofibromatous Proliferation in A Case of Von Recklinghausen's Disease - A Case Report.

Authors:  Honnappa Sridhar; Rau R Aarathi; Mysorekar Vijaya; Jalihal Umesh
Journal:  J Clin Diagn Res       Date:  2013-09-10

Review 2.  The differential diagnosis and surveillance of hereditary gastrointestinal polyposis syndromes.

Authors:  Stefan Aretz
Journal:  Dtsch Arztebl Int       Date:  2010-03-12       Impact factor: 5.594

3.  Solitary colonic polypoid ganglioneuroma.

Authors:  Isabel Maria Mendez; Teresa Pereda; Francisco Javier Rodriguez; Rafael Funez; Andres Sanchez
Journal:  Diagn Pathol       Date:  2008-04-29       Impact factor: 2.644

4.  A case of recurrent intestinal ganglioneuromatous polyposis accompanied with mesenteric schwannoma.

Authors:  Qi-Ming Wang; Dan Jiang; Hong-Ze Zeng; Yi Mou; Hang Yi; Wei Liu; Qi-Shan Zeng; Chun-Cheng Wu; Cheng-Wei Tang; Bing Hu
Journal:  Dig Dis Sci       Date:  2014-06-14       Impact factor: 3.199

5.  Novel Germline PTEN Mutation Associated with Cowden Syndrome and Osteosarcoma.

Authors:  Christian Lopez; Mohammad Abuel-Haija; Luis Pena; Domenico Coppola
Journal:  Cancer Genomics Proteomics       Date:  2018 Mar-Apr       Impact factor: 4.069

6.  Acinic cell carcinoma of the retromolar trigone region: expanding the tumor phenotype in Cowden syndrome?

Authors:  Hugo Villeneuve; Steve Tremblay; Polymnia Galiatsatos; Nancy Hamel; Louis Guertin; Renald Morency; Marc Tischkowitz
Journal:  Fam Cancer       Date:  2011-12       Impact factor: 2.375

Review 7.  A Comprehensive Review of Pediatric Tumors and Associated Cancer Predisposition Syndromes.

Authors:  Sarah Scollon; Amanda Knoth Anglin; Martha Thomas; Joyce T Turner; Kami Wolfe Schneider
Journal:  J Genet Couns       Date:  2017-03-29       Impact factor: 2.537

Review 8.  Genetics of the hamartomatous polyposis syndromes: a molecular review.

Authors:  Hui-Min Chen; Jing-Yuan Fang
Journal:  Int J Colorectal Dis       Date:  2009-04-21       Impact factor: 2.571

9.  Diffuse intestinal ganglioneuromatosis an uncommon manifestation of Cowden syndrome.

Authors:  Maria Teresa Herranz Bachiller; Jesus Barrio Andrés; Fernando Pons; Noelia Alcaide Suárez; Rafael Ruiz-Zorrilla; Lorena Sancho Del Val; Sara Lorenzo Pelayo; Carlos De La Serna Higuera; Ramon Atienza Sánchez; Manuel Perez Miranda
Journal:  World J Gastrointest Oncol       Date:  2013-02-15

Review 10.  Cowden syndrome: a critical review of the clinical literature.

Authors:  Robert Pilarski
Journal:  J Genet Couns       Date:  2008-10-30       Impact factor: 2.537

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.